BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27934920)

  • 1. Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model.
    Ni X; Gao Y; Wu Z; Ma L; Chen C; Wang L; Lin Y; Hui L; Pan G
    Sci Rep; 2016 Dec; 6():38694. PubMed ID: 27934920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Bile Acids Responsible for Inhibiting the Bile Salt Export Pump, Leading to Bile Acid Accumulation and Cell Toxicity in Rat Hepatocytes.
    Oizumi K; Sekine S; Fukagai M; Susukida T; Ito K
    J Pharm Sci; 2017 Sep; 106(9):2412-2419. PubMed ID: 28552691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
    Chatterjee S; Richert L; Augustijns P; Annaert P
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
    Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
    Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
    Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
    Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
    Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
    Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
    Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.
    Marrone J; Danielli M; Gaspari CI; Marinelli RA
    IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
    Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
    Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.
    Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M
    Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
    Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
    Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
    Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
    Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: Current status and disadvantages to overcome.
    Sakai Y; Iwao T; Susukida T; Nukaga T; Takemura A; Sekine S; Ito K; Matsunaga T
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):264-271. PubMed ID: 31285099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
    Cheng Y; Woolf TF; Gan J; He K
    Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
    Jackson JP; Brouwer KR
    Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
    Ogimura E; Sekine S; Horie T
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition.
    Ryan J; Morgan RE; Chen Y; Volak LP; Dunn RT; Dunn KW
    Drug Metab Dispos; 2018 May; 46(5):704-718. PubMed ID: 29467212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.
    Petrov PD; Fernández-Murga L; Conde I; Martínez-Sena T; Guzmán C; Castell JV; Jover R
    Arch Toxicol; 2020 Feb; 94(2):589-607. PubMed ID: 31894354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
    Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
    Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.